SuperworthAquestive Therapeutics market cap AQST
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $502M
- Highest close in our data
- $786.9M
- Jan 2026
Aquestive Therapeutics is worth $502M at the close on Oct 23, 2026, at $4.00 a share.
That is down 26% over the last year and up 151% over five years.
Its highest close in our data was $786.9M in Jan 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $502M | $359.9M | $786.9M | −31% |
| 2025 | $730.8M | $233.4M | $778.4M | +128% |
| 2024 | $320.9M | $156.2M | $502.6M | +138% |
| 2023 | $134.9M | $42.1M | $159.6M | +176% |
| 2022 | $48.9M | $26.4M | $155M | −69% |
| 2021 | $156.2M | $118.9M | $255.8M | −13% |
| 2020 | $179.9M | $56.4M | $305.6M | +30% |
| 2019 | $138.6M | $76.1M | $200.6M | −10% |
| 2018 | $153.6M | $153.6M | $472.9M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Aquestive Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| AQSTAquestive Therapeutics | $502M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| NATRNatures Sunshine Products | $213.8M |
| OMEROmeros | $1.2B |
| Peer median | $597.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Aquestive Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.